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Ligature supra-diaphragmatique du canal thoracique, video-assistée, pour 
chylothorax récurrent non traumatique. 
Introduction 
Un chylothorax est une pathologie comprenant des manifestations respiratoires, 
nutritionnelles et immunologiques. La récidive du chylothorax ou l'échec du 
traitement conservateur imposent un traitement chirurgical. Ce travail rapporte 
notre expérience de ligature supra-diaphragmatique, vidéo-assistée du canal 
thoracique, pour chylothorax récurrent non traumatique. 
Patients et méthodes 
Entre 1999 et 2004, nous avons recensé six observations (quatre du côté droit, 
un du côté gauche et un bilateral) Le chylothorax s'est développé chez trois 
patients traités par radio et chimiothérapie pour tumeur (deux lymphomes et une 
tumeur du sein) un dans le contexte d'une lymphangioléiomatose et un après 
greffe cardiaque. 
Résultats 
Les patients ont bénéficié sous anesthésie générale, d'une ligature du canal 
thoracique supra-diaphragmatique, vidéo-assistée. Le temps opératoire moyen a 
été de 102 minutes. Le chylothorax a régressé chez cinq des six patients en sept 
jours. Un patient a été repris par thoracotomie droite au huitième jour pour 
chylothorax persistant. Dans la phase post-opératoire, un patient a développé 
une détresse respiratoire nécessitant une ventilation mécanique. Un autre patient 
a présenté un chylopéritoine important traité par un stent de Le Veen®. Le 
séjour moyen a été de quatorze jours sans mortalité péri-opératoire. 
Conclusion 
Le traitement du chylothorax non traumatique récurrent est, en première 
intention, un traitement médical. En cas de récidive ou d'échec du traitement 
conservateur, le traitement chirurgical par ligature du canal thoracique supra-
diaphragmatique, vidéo-assistée, permet de traiter avec succès le chylothorax 
récurrent non traumatique. 
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Abstract 
Background: Chylothorax is an uncommon disorder with respiratory, nutritional and immunological manifestations. Surgical management is 
indicated in case of recurrence or failure after conservative treatment. We report our experience with video-assisted right-sided supradiaphrag-
matic thoracic duct ligation for non-traumatic, non-postoperative persistent or recurrent chylothorax. Patients and methods: The medical 
records of six patients operated atour institution between 1999 and 2004 were retrospectively reviewed. A right-sided chylothorax was found in 
four patients, a left-sided in one, and a bilateral in one. Three patients developed chylothorax after chemotherapy and chest irradiation for 
malignant diseases (lymphoma in two patients and breast cancer in one), one in the context of lymphangioleiomyomatosis, one due to a non-
diagnosed lymphoma, and one after heart transplantation. Results: The mean operative time was 102 min, with an average length of hospital stay 
of 14 days. Persistent cessation of chylous effusion within 7 days after surgery was observed in 5/6 patients without recurrence during a mean 
follow-up time of 41 months. One patient with undiagnosed mediastinal lymphoma required re-operation and thoracic duct ligation on day 8 by 
right-sided thoracotomy due to persistent chylothorax. No 30-day mortality was recorded. Two patients presented postoperative complications 
including respiratory insufficiency requiring mechanical ventilation in one, and chylous ascites development requiring peritoneo-venous LeVeen 
shunting in one patient. Conclusions: Recurrent or persistent non-traumatic chylothorax may be successfully treated by video-assisted right 
supradiaphragmatic thoracic duct ligation. 
© 2006 Elsevier B.V. All rights reserved. 
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1. Introduction 
Chylothorax is an uncommon but vexing clinical disorder 
[1-4] and may be a life-threatening condition if left 
untreated [2]. lt may be related to various underlying causes 
such as penetrating or blunt trauma to the neck, chest or 
upper abdomen, surgery involving the oesophagus, lung, 
pleura, mediastinum and heart, and diseases such as 
lymphangioleiomyomatosis or lymphoma [1-6]. 
The clinical presentation of chylothorax is mainly related 
to the presence of pleural effusion and nutritional deteriora-
tion resulting from loss of large amounts of electrolytes, 
proteins, lipids and vitamins [1-4]. Immune deficiency and 
lymphopenia are other significant characteristics of the 
disease [1,2,4]. 
The optimal treatment of chylothorax is still controver-
sial and depends on the setting in which it evolves. 
Conservative management is usually recommended in first 
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line and consists of total parenteral nutrition or low fat, 
medium-chain triglyceride supplemented regimens for 
several weeks [1-4]. However, repeated thoracocentesis 
or chest tube drainage is often required du ring conservative 
treatment in order to relief dyspnea, which bears an 
increased risk of pleural infection [1,2,4]. Refractory 
chylothorax after failure of medical therapy is usually 
addressed for surgery. Several surgical procedures have 
been described in this context including pleurodesis, 
pleurectomy, right supradiaphragmatic thoracic duct liga-
tion and pleuro-peritoneal shunting [1-4, 7]. Thoracic duct 
ligation has been introduced by Lampson [8] in 1948 which 
decreased the mortality rate from 50% to 15%. lt has been 
recognised that surgical intervention to ligate the thoracic 
duct should be performed before the debilitating complica-
tions of chylothorax have manifested. Although thoracic 
duct ligation has been accomplished by thoracoscopy, most 
surgeons rely on open procedure through a right thoracot-
omy. Thoracic duct ligation performed by a VATS approach 
has not gained wide acceptance since most reports deal with 
anecdotal observations and are based mainly on case reports 
[5, 9-21]. We report our experience with thoracoscopic right 
supra-diaphragmatic thoracic duct ligation in a small series 
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of six patients presenting with recurrent or persisting non· 
traumatic chylothorax. 
2. Patients and methods 
All patients presenting with symptomatic, recurrent or 
persisting non-traumatic chylothorax who underwent 
video-assisted right supradiaphragmatic thoracic duct 
ligation between 1999 and 2004 at our institution were 
the subject of this report. Inclusion criteria for video· 
assisted supradiaphragmatic duct ligation consisted of the 
presence of persisting or recurrent chylothorax with 
elevated triglyceride levels > 1.3 mmol/l in the pleural 
effusion following unsuccessful conservative management 
and chest tube drainage. CT scan of the chest was 
performed after drainage in order to confirm full expansion 
of the lungs . The presence of an entrapped Lung by 
loculated effusions or a pleural peel was an exclusion 
criteria for video-assisted supradiaphragmatic thoracic 
duct ligation. 
2. 1. 1. Surgical technique 
General anaesthesia with selective double lumen 
intubation was performed and the patient was placed in 
a left lateral position . After exclusion of the right lung, two 
7 mm thoracoports were inserted in the mid-axillary line at 
the levels of 8th and 10th intercostal spaces, respectively 
(Fig. 1 a). The optic and a suction device were introduced 
which allowed the emptying and inspection of the pleural 
cavity. A 4 cm incision was then performed at the postero· 
lateral level of the 9th interœstal space in order to 
introduce conventional surgical instruments without thor· 
acoport (Fig . 1 a). The inferior border of the lung was 
grasped by an endoscopie duval forceps and the pulmonary 
ligament was divided (Fig. 1 b). The azygous vein was 
identified and the parietal pleura was incised between the 
azygous vein and the vertebral bodies, from the diaphrag-
matic hiatus to the inferior pulmonary vein. The oesophagus 
was dissected from the hiatus to the inferior pulmonary vein 
and retracted medially (Fig. 1 c). The descending aorta 
was dissected behind the esophagus on its medial aspect 
Fig . 1. Video-assisted right-sided supradiaphragmatic thoracic duct ligation for non-traumatic persistent or recurrent chylothorax; (a) positioning of two 7 mm 
trocarts in the mid -axillary line at the levels of the 8th and 10th intercostal space , and a 4 cm incision at the posterior Level of the 9th intercostal space; (b) 
visualisation and division of the pulmonary ligament; (c) division of the parietal pleura along azygous vein and the esophagus from the hiatus to the inferior pulmonary 
vein , dissection and medial retraction of the esophagus and dissection of the ventral part of the descending aorta; and (d) mass ligation of all fibro-fatty tissue 
between the azygous vein, the vertebral bodies, the esophagus and the aorta by three ligatures of 3-0 prolene'll> . 
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Fig. 2. Schematic drawing of video-assisted right supradiaphragmatic thoracic 
duct ligation. Mass ligation of all the fibro-fatty tissue between the oesopha-
gus, the dorsal aspect of the aorta, the azygos vein and the vertebral bodies 
was performed by using three ligatures of non-resorbable 3-0 polypropylene 
(prolene®) at a distance of 2 cm each, beginning at the level of the diaphragm . 
(Fig . 1d). Mass ligation of all the fibro-fatty tissue between 
the oesophagus, the dorsal aspect of the aorta, the azygos 
vein and the vertebral bodies was performed by using three 
ligatures of non-resorbable 3-0 polypropylene (prolene®) 
at a distance of 2 cm each, beginning at the level of the 
diaphragm (Fig. 2 ). An endoscopie device was used for this 
purpose. Chest tube drainage (28F) was performed after 
removal of the thoracoports . Oral feeding without dietary 
restriction was started at postoperative day 1. 
3. Results 
The patient's demographics and characteristics are 
summarised in Table 1. A right-sided chylothorax was seen 
in four patients, a left-sided in one, and a bilateral in one. 
Table 1 
Fig . 3. Postoperative chest X- ray of patient 1 who developed respiratory 
insufficiency due to infiltration of the right lower lobe and chylous bronchor· 
rhoe after successful video-assisted thoracic duct ligation. 
Three patients developed a chylothorax after chemotherapy 
and chest irradiation for malignant diseases (lymphoma in 
two patients and breast cancer in one) , one in the context of 
lymphangioleiomyomatosis, one due to a non-diagnosed 
lymphoma, and one after heart transplantation. The duration 
of chylothorax before thoracic duct ligation ranged from 7 to 
14 days. 
The mean operative time was 102 min (range 50- 140 min) 
and the average hospitalisation time was 14 days (range 8- 28 
days). No perioperative complications were observed in 
patients with a left-sided chylothorax treated by video-
assisted right supradiaphragmatic thoracic duct ligation. The 
mean time of chest tube drainage was 7 days ranging from 6 to 
10 days. lmmediate cessation of chylous fluid secretion was 
observed in 5 / 6 patients despite the fact that the patients had 
eaten normally starting at postoperative day 1, without any 
Patient's characteristics and postoperative results after video-assisted right-sided supradiaphragmatic thoracic duct ligation 
Patient number Age (years) Sex Cause Side Operative time (min) 
2 
3 
4 
6 
51 F RT·CHT3 l + r 140 
51 F RT-CHTb l 130 
42 M RT-CHTc 50 
57 M Heart TX 88 
49 M LAM d 100 
57 F Lymphoma 70 
a Mediastinal irradiation and chemotherapy for lymphoma 20 years ago. 
b Chest wall irradiation and chemotherapy for breast cancer 15 years ago. 
c Chest wall irradiation and chemotherapy for breast cancer 15 years ago. 
d Pulmonary lymphangioleiomyomatosis. 
Drainage (days) Recurrence Complications 
10 Respiratory insufficiency 
6 
6 
10 
7 
8 Day 8, re ·operation 
M. Christodoulou et al. / European Journal of Cardio-thoracic Surgery 29 (2006) 810-814 813 
diet or restriction. One patient was re·operated by right-sided 
thoracotomy on day 8 postoperatively due to persistent 
chylothorax. The revisited chest revealed enlarged lymph 
nodes along the posterior lower mediastinum consistent with 
malignant lymphoma on frozen section examination. Mass 
ligations were performed using 2·0 mersilene® sutures at 
three different levels through thoracotomy, which was 
followed by cessation of chylous drainage within 2 days. 
There was no 90-day postoperative morbidity in 4/6 patients. 
One patient (status post radiochemotherapy for mediastinal 
lymphoma) developed postoperative infiltration of the right 
lower lobe associated with chylous bronchorrhoe and respira· 
tory insufficiency requiring tracheotomy and mechanical 
ventilation without recurrent chylothorax (Fig. 3). Another 
patient (status post heart transplantation) developed a 
chylous ascites on postoperative day 10 without recurrent 
chylothorax and treated by a Le Veen peritoneo-venous shunt. 
No recurrent pleural effusion was observed in any patient 
during a mean follow·up time of 41 months. 
4. Discussion 
Non·traumatic, non-postoperative chylothorax may be 
addressed for surgery in case of recurrence or persistence 
despite adequate conservative management [1,2,5]. Medical 
treatment of a chylothorax related to malignancies is 
associated with a significant failure rate due to direct 
infiltration, external compression or rupture of the thoracic 
duct by the underlying disease [1,6]. The indications for a 
surgical approach consist of an average daily chylous loss 
exceeding 1500 ml in adults or 1 OO ml per year of age in 
children for a 5-day period, and a continuous drainage of chyle 
over a period of 14 days of conservative management 
[1,2,7,22]. Timing of surgery is still a matter of debate and 
various surgical procedures have been described. Supradiaph· 
ragmatic mass ligation of the thoracic duct through right·sided 
thoracotomy is generally considered as the modality of choice 
in the absence of signs of restriction and entrapped lung by a 
thickened pleural peel on chest CT [2,4,20,23]. The dis· 
advantage consists of the morbidity related to thoracotomy 
performed in fail and malnourished patients. 
lt has been demonstrated that thoracic duct ligation may 
be successfully performed by using video-assisted thoraco· 
scopy in order to avoid a thoracotomy, with apparently lesser 
postoperative pain, shorter recovery time and hospital stay 
[9-21]. However, this technique has not gained wide 
acceptance at date due to the rarity of this intervention. 
Only few reports relying mainly on anecdotic observations 
have been published [9-21]. Various procedures have been 
described for this purpose including ligation, stapling or 
clipping of the thoracic duct, or fibrin glue application in 
order to achieve pleurodesis [12-17]. The main advantage of 
this technique is the avoidance of thoracotomy, which may 
result in lesser reluctance of physicians towards a surgical 
approach, quicker referral for surgery and as a consequence, 
a decreased morbidity related to chylous loss. 
Our results emerging from a small series of patients with 
recurrent or persisting non·traumatic chylothorax undergoing 
video-assisted thoracic duct ligation endorse the results of 
previous reports. The procedure is safe and efficient provided 
there are no restriction or entrapment of the Lung by a chronic 
pleural peel underlining the importance of preoperative 
assessment by chest CT scan. All patients in our series 
underwent right·sided supradiaphragmatic mass ligation of 
the fibro·fatty tissue between azygous vein, esophagus, 
descending aorta and vertebral bodies irrespective of the 
side of chylothorax [22-25]. lndividual dissection and ligation 
of the thoracic duct bears the risk of missing anatomie 
variations and duplications of the thoracic duct during surgery 
which may occur in as much as 40% of the patients [25]. 
The majority of our patients i'evealed a low operation 
time, duration of chest tube drainage and hospitalisation, 
and no postoperative morbidity. Patients with a left·sided 
chylothorax treated by a video-assisted right supradiaphrag· 
matie thoracic duct ligation did equally as well as those with 
a right·sided chylothorax. No recurrence was observed in 5/6 
patients after a mean follow·up time of 41 months. However, 
one patient with lymphoma situated in the posterior aspect 
of the mediastinum revealed a persistent chylothorax after 
video-assisted thoracic duct ligation with cessation after a 
redo-operation through thoracotomy. One patient developed 
postoperative respiratory insufficiency due to right lower 
lobe infiltration and chylous bronchorrhoe, which required 
prolonged mechanical ventilation and tracheostomy 
although there was no residual pleural effusion after duct 
ligation. This patient developed right·sided chylothorax 
several years after radiochemotherapy for mediastinal 
lymphoma. Another patient developed chylous ascites after 
successful thoracic duct ligation for chylothorax occurring 
after heart transplantation. These observations underline 
the somewhat unpredictable and poorly interpretable course 
after surgical interventions for non·traumatic or non·post· 
operative lymphatic disorders. 
Our results demonstrate that video-assisted right·sided 
supradiaphragmatic thoracic duct ligation offers rewarding 
long-term results for the treatment of recurrent or persistent 
non-traumatic and non-operative chylothorax, irrespective 
of the side of its manifestation and its underlying cause. The 
main advantage of the VATS approach is its low morbidity in 
already debilitated patients, which may result in better 
acceptance of surgery for this disorder and earlier referral for 
surgical intervention. 
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